VOYA Investment Management
VERV

VOYA Investment Management’s Verve Therapeutics VERV Stock Holding History

VOYA Investment Management’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-18,937
Closed -$213K – 2651
2025
Q2 		$213K Sell
18,937
-730
-4% -$4.16K ﹤0.01% 2304
2025
Q1 		$89.9K Sell
19,667
-2,494
-11% -$16.7K ﹤0.01% 2456
2024
Q4 		$125K Sell
22,161
-1,538
-6% -$8.68K ﹤0.01% 2523
2024
Q3 		$115K Buy
23,699
+155
+0.7% +$900 ﹤0.01% 2629
2024
Q2 		$115K Buy
23,544
+2,803
+14% +$17.6K ﹤0.01% 2634
2024
Q1 		$275K Buy
20,741
+42
+0.2% +$557 ﹤0.01% 2292
2023
Q4 		$289K Buy
20,699
+302
+1% +$3.74K ﹤0.01% 2371
2023
Q3 		$270K Buy
20,397
+375
+2% +$6.04K ﹤0.01% 2356
2023
Q2 		$375K Buy
20,022
+2,085
+12% +$34.7K ﹤0.01% 2246
2023
Q1 		$259K Hold
17,937
– – ﹤0.01% 2401
2022
Q4 		$347K Buy
17,937
+599
+3% +$15.9K ﹤0.01% 2232
2022
Q3 		$596K Buy
17,338
+3,690
+27% +$118K ﹤0.01% 1919
2022
Q2 		$209K Buy
+13,648
New +$211K ﹤0.01% 2374
2022
Q1 		– Sell
-6,074
Closed -$224K – 2758
2021
Q4 		$224K Sell
6,074
-202
-3% -$8.49K ﹤0.01% 2444
2021
Q3 		$295K Buy
+6,276
New +$369K ﹤0.01% 2355

Other funds holding VERV

GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

VOYA Investment Management's VERV Position: Q3 2025 in Review

VOYA Investment Management sold out of Verve Therapeutics (VERV) in Q3 2025, closing a stake of 18,937 shares — an estimated $213K sold.

VOYA Investment Management first reported a position in VERV in Q3 2021 and held it in 15 quarters. The position peaked at $596K in Q3 2022. 6 funds tracked by Wall St. Rank hold VERV as of Q3 2025.

  • VOYA Investment Management reported no remaining Verve Therapeutics position as of Q3 2025 after selling out during the quarter.
  • VOYA Investment Management sold 18,937 Verve Therapeutics shares in Q3 2025, an estimated $213K.
  • VOYA Investment Management first reported a position in Verve Therapeutics in Q3 2021 and held it in 15 quarters.
  • VOYA Investment Management's Verve Therapeutics position peaked at $596K in Q3 2022.
  • 6 funds tracked by Wall St. Rank held Verve Therapeutics as of Q3 2025.

Based on VOYA Investment Management's 13F filing for Q3 2025, filed 9 Oct 2025.